AllerFund Fund Manager Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Type

Private Equity Firm

Location

Scarsdale NY US

Alternative Asset Classes

Established

2020

Firm Ownership

Independent Firm

Investment Team Staff

Total Staff

Allerfund is a venture capital firm that invests in early-stage companies focused on social impact for the food allergy community. The firm's goal is to develop new therapies and products. The firm will target industries such as therapeutics, medical devices, diagnostics, digital technologies, and consumer products across the U.S.

Asset Class	No. of Funds Currently Managed	Strategies
Private Equity	2	Early Stage
Real Estate	-	-
Private Debt	-	-
Infrastructure	-	-
Natural Resources	-	-

Asset Class	No. of Funds Currently Managed	AuM	Date of AuM	Strategies
Hedge Funds	0			-

Want to see more?

Request a demo for full access to this profile.

2 Known Decision Makers

Contact Name	Position	Location	Email	Telephone	Asset Class
	Managing Partner	Scarsdale, US			PE
	Managing Partner	Scarsdale, US			PE

Showing 2 of 2 known decision makers at AllerFund

Preqin screens the most influential contacts in alternatives, so you only reach the key decision makers

Request a Demo to see more

2 Private Capital Funds Managed

Fund Name	Vintage	Strategy	Status	Fund Structure	Closed Size (MN)	Target Size (MN)	Primary Region Focus
		Early Stage	Raising	Commingled			North America
		Venture (General)	Closed	Commingled			North America

Showing 2 of 2 private capital fund managed by AllerFund